Skip to content
2000
Volume 6, Issue 4
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Background

The Indian Council of Medical Research (ICMR), under the Ministry of Health and Family Welfare, recommended chemoprophylaxis with Hydroxychloroquine (HCQ) for asymptomatic healthcare workers treating patients with suspected or confirmed COVID-19 disease during the initial period of the pandemic. Compliance remains a major determining factor behind the success of any community prophylaxis program.

Objective

The study aimed to assess the extent of compliance with the HCQ prophylaxis schedule as per ICMR guidelines among healthcare workers and to find out the factors associated with compliance.

Methods

Informed consent was obtained from the study participants, and a questionnaire on parameters and associated factors affecting compliance were filled out by every study participant upon completion of their HCQ prophylaxis.

Results

A total of 160 participants were enrolled in the study. The majority of the staff enrolled was the nursing staff (34%). 66% of the total participants were involved in the care of the suspected or confirmed case of COVID-19. The major source of information about HCQ prophylaxis for COVID-19 infection among all the participants was from the institutional circular (56%). 10% of healthcare workers believed that HCQ could give them 100% prevention against COVID-19 infection. 56% of the enrolled healthcare workers consumed the medicine on the same day of collection throughout the schedule. 24% of enrolled healthcare workers completed the full course as per ICMR guidelines. The most motivating factor for compliance was the presence of cases of COVID-19 in the hospital. The most common factor for lack of compliance among enrolled healthcare workers was cited to be no contact with COVID-19 positive patients.

Conclusion

In our study, 24% of healthcare workers enrolled for HCQ prophylaxis completed the full course of the prescribed regimen as per ICMR guidelines. The main reason for the lack of compliance was the absence of direct contact with COVID-19 positive patients, followed by fear of ADRs.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975300190240627073800
2024-07-05
2025-10-03

  • From This Site

    /content/journals/covid/10.2174/0126667975300190240627073800
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Coronavirus disease2019 (COVID-19) Situation Report -121. World Health Organisation.2019Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public?adgroupsurvey={adgroupsurvey}&gad_ source=1&gclid=Cj0KCQjw97SzBhDaARIsAFHXUWCY4nJ14n7hvoGgSX16wHQ8Me2QyJ7yVIQc-LplMukwImtN8GpV6oQaAtw8EALw_wcB
    [Google Scholar]
  2. DawoodA.A. Reasons for discontinuing the use of Hydroxychloroquine in the treatment of the Novel Coronavirus.Asian J Pharmac Analy202111217918010.52711/2231‑5675.2021.00030
     [Google Scholar]
  3. NareshB.V. A review of the 2019 novel coronavirus (COVID-19) pandemic.Asian J Pharmac Res202010323323810.5958/2231‑5691.2020.00040.4
     [Google Scholar]
  4. RokadeM. KhandagaleP. Coronavirus disease: A review of a new threat to public health.Asian J Pharmac Res202010324124410.5958/2231‑5691.2020.00042.8
     [Google Scholar]
  5. WHO Coronavirus Disease (COVID-19) Dashboard. Geneva: World Health Organization.2020https://covid19.who.int/
  6. JainV.K. IyengarK. VaishA. VaishyaR. Differential mortality in COVID-19 patients from India and western countries.Diabetes Metab. Syndr.20201451037104110.1016/j.dsx.2020.06.067 32640415
     [Google Scholar]
  7. SharmaA. MohananK. Obstacles faced by nurses working in Covid-19 unit: A developing country view point.Asian J. Nurs. Educ. Res.202010445946210.5958/2349‑2996.2020.00098.1
     [Google Scholar]
  8. NashwanA.J. MathewR.G. AnilR. The safety, health, and well-being of healthcare workers during COVID-19: A scoping review.AIMS Public Health202310359360910.3934/publichealth.2023042 37842272
     [Google Scholar]
  9. LiuJ. CaoR. XuM. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.Cell Discov.2020616
     [Google Scholar]
  10. Indian Council of Medical Research (ICMR) Advisory on the use of hydroxy-chloroquine as prophylaxis for SARS-CoV-2 infection. ICMR.2020Available from: https://www.mohfw.gov.in/pdf/AdvisoryontheuseofHydroxychloroquinasprophylaxisforSARSCoV2infection.pdf
  11. Indian Council of Medical Research (ICMR) Revised Advisory on the use of hydroxy-chloroquine as prophylaxis for SARS-CoV-2 infection. ICMR.2020Available from: https://www.mohfw.gov.in/pdf/RevisedadvisoryontheuseofhydroxychloroquineasprophylaxisforSARSCOVID19infection.pdf
  12. PandaS. ChatterjeeP. AnandT. Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19.Indian J. Med. Res.2020151545946710.4103/ijmr.IJMR_2234_20 32611916
     [Google Scholar]
  13. ShahS. DasS. JainA. MisraD.P. NegiV.S. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease‐19 (COVID‐19).Int. J. Rheum. Dis.202023561361910.1111/1756‑185X.13842 32281213
     [Google Scholar]
  14. HongH. FriedlandA. HuM. Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: A meta-analysis of randomised clinical trials.BMJ Open2023136e06530510.1136/bmjopen‑2022‑065305 37328184
     [Google Scholar]
  15. NaggieS. MilstoneA. CastroM. Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: A randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ).Int. J. Infect. Dis.2023129404810.1016/j.ijid.2023.01.019 36682681
     [Google Scholar]
  16. Llanos-CuentasA. SchwalbA. QuintanaJ.L. Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: Early termination of a phase 3, randomised, open-label, controlled clinical trial.BMC Res. Notes20231612210.1186/s13104‑023‑06281‑7 36849996
     [Google Scholar]
  17. GurjarM. HaldarR. MishraP. Knowledge and compliance of hydroxychloroquine prophylaxis for severe acute respiratory syndrome coronavirus 2 infection among Indian health-care workers.J. Res. Pharm. Pract.2022111333910.4103/jrpp.jrpp_50_21 36277967
     [Google Scholar]
  18. MohakudaS. PathakB. SinghA.R. TilakT.V. HarikrishnanP. COVID-19 preventive measures among healthcare workers: Desperate times, desperate measures.J Mar Med Soc202038387
     [Google Scholar]
  19. JunejaS. KaurS. RanaS. Knowledge, attitude, and practices of healthcare workers on the use of hydroxychloroquine prophylaxis against COVID-19 infection.J Health Sci Res20211222730
     [Google Scholar]
  20. RanaP. GhadlingeM. SinghP. ChandaneR.D. KhannaA. Doctors perception of the use of hydroxychloroquine as prophylaxis for COVID-19 infection.Pharmac Biomed Res2021729710410.18502/pbr.v7i2.7362
     [Google Scholar]
  21. SinghA. KumarH. GuptaP. Assessment of knowledge, attitude, and practices towards hydroxy chloroquine pre-exposure prophylaxis among health care professionals.Indian J. Community Health202032468168710.47203/IJCH.2020.v32i04.012
     [Google Scholar]
  22. García-AlbénizX. del AmoJ. PoloR. Morales-AsencioJ.M. HernánM.A. Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19.Eur. J. Epidemiol.202237878979610.1007/s10654‑022‑00891‑4 35943669
     [Google Scholar]
  23. LewisK. ChaudhuriD. AlshamsiF. The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials.PLoS One2021161e024477810.1371/journal.pone.0244778
     [Google Scholar]
  24. KumarJ. JainS. MeenaJ. YadavA. Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis.J. Infect. Chemother.202127688288910.1016/j.jiac.2021.02.021 33678548
     [Google Scholar]
  25. Martins-FilhoP.R. FerreiraL.C. HeimfarthL. AraújoA.A.S. Quintans-JúniorL.J. Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.Lancet Regional Health Americas2021210006210.1016/j.lana.2021.100062 34485970
     [Google Scholar]
  26. Sanchez-GomezM. SadovyyM. BresoE. Health-care professionals amid the COVID-19 pandemic: How emotional intelligence may enhance work performance traversing the mediating role of work engagement.J. Clin. Med.20211018407710.3390/jcm10184077 34575186
     [Google Scholar]
  27. Rojas-SerranoJ. Portillo-VásquezA.M. Thirion-RomeroI. Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial.PLoS One2022172e026198010.1371/journal.pone.0261980 35139097
     [Google Scholar]
  28. RajasinghamR. BangdiwalaA.S. NicolM.R. Hydroxychloroquine as pre-exposure prophylaxis for coronavirus disease 2019 (COVID-19) in healthcare workers: A randomized trial.Clin. Infect. Dis.20217211e835e84310.1093/cid/ciaa1571 33068425
     [Google Scholar]
  29. The National Task Force on COVID-19Consideration from exclusion of ivermectin and hydroxychloroquine from the clinical guidance for management of adult COVID-19 patients.Available from: https://www.icmr.gov.in/pdf/covid/techdoc/Considerations_for_Exclusion_of_IVM_and_HCQ.pdf
  30. TendulkarP. PandeyP. PandaP.K. Comparative study between the first and second wave of COVID-19 deaths in India: A single center study.Cureus2023154e3747210.7759/cureus.37472 37187656
     [Google Scholar]
  31. PurohitN. ChughY. BahugunaP. PrinjaS. COVID-19 management: The vaccination drive in India.Health Policy Technol.202211210063610.1016/j.hlpt.2022.100636 35531441
     [Google Scholar]
/content/journals/covid/10.2174/0126667975300190240627073800
Loading
Compliance Among Healthcare Workers on Hydroxychloroquine Prophylaxis in a Tertiary Care Teaching Hospital during COVID-19 Pandemic
Coronaviruses 6, E050724231687 (2025); https://doi.org/10.2174/0126667975300190240627073800
/content/journals/covid/10.2174/0126667975300190240627073800
/content/journals/covid/10.2174/0126667975300190240627073800
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): COVID-19; Healthcare workers; hydroxychloroquine; ICMR; prophylaxis; SARS-CoV-2

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test